Clinical Study
Maternal Thyroid Dysfunction and Neonatal Thyroid Problems
Table 1
Demographic and laboratory characteristics of patients.
| | | Group I () | Group II () | Group III () | |
| | Maternal age (median; min–max) | 31 (25–39) | 29.5 (29–39) | 31 (29–44) | 0.6 | | Parity (primipar/multipar) | 3/10 | 7/14 | 37/55 | 0.4 | | Previous abortus history (%) | 4 (26.7) | 1 (4.5) | 11 (12) | 0.2 | | Previous preterm birth (%) | 3 (20) | 0 | 0 |
*
| | Current preterm delivery (%) | 9 (60) | 6 (27.3) | 17 (18.5) | 0.002 | | Multiple pregnancy (%) | 4 (26.7) | 2 (9.1) | 13 (14.1) | 0.3 | | Maternal TSH** (median; min–max) | 5 (0.9–14) | 2.7 (0.2–18.9) | 1.8 (1.1–3.1) | <0.001 | | Maternal FT4** (median; min–max) | 1.1 (0.7–1.7) | 0.9 (0.1–1.6) | 1.2 (1–1.7) | <0.001 | | Birth weight (gram) (median; min–max) | 2840 (970–3600) | 3180 (1700–4230) | 3140 (1200–4550) | 0.3 | | Gestational age (week) (median; min–max) | 36.5 (29–38) | 38 (32–40) | 38 (29.5–41) | 0.002 | | Sex (female/male) (%) | 33.3/66.7 | 40.9/59.1 | 54.3/45.6 | 0.1 | | Intrauterine growth retardation (%) | 2 (15.4) | 1 (4.8) | 8 (8.8) | 0.6 | | NICU admission (%) | 6 (46.7) | 8 (31.8) | 3 (3.3) | <0.001 |
|
|
Statistical analysis inapplicable.
**Measurements were obtained at 3rd trimester.
|
